This number includes a "lost productivity" calculation, but does not include costs associated with diseases that are not classically secondary to diabetes, but are associated with immune system diseases generally. It is estimated that the true figure may be as high as $140 billion. See: http://www.diabetes.org/ada/c20f.asp.